Management of Severe Hypertension

Classification and Initial Assessment

Hypertensive emergency is defined as severe BP elevation (>180/120 mmHg) with evidence of new or worsening target organ damage, according to the American Heart Association 1, 2
Hypertensive urgency is severe BP elevation without progressive target organ damage, as defined by the American Heart Association 1, 2
Assessment for signs of target organ damage, including hypertensive encephalopathy, intracranial hemorrhage, acute ischemic stroke, acute myocardial infarction, acute left ventricular failure with pulmonary edema, unstable angina, aortic dissection, acute renal failure, or eclampsia, is crucial in determining the severity of hypertension 1, 2

Admitting patients to the ICU for continuous BP monitoring and parenteral administration of appropriate antihypertensive agents is recommended by the American College of Cardiology 1, 2, 3
The 1-year mortality rate for untreated hypertensive emergencies exceeds 79%, highlighting the importance of prompt treatment 1, 2
For patients with compelling conditions, such as aortic dissection, severe preeclampsia/eclampsia, or pheochromocytoma crisis, reducing SBP to <140 mmHg during the first hour is recommended by the American Heart Association 1, 2
For patients without compelling conditions, reducing SBP by no more than 25% within the first hour is recommended, followed by a gradual reduction to normal over the next 24-48 hours, as suggested by the European Society of Cardiology 1, 2

First-line options for IV medications include labetalol, nicardipine, and clevidipine, as recommended by the American College of Cardiology 1, 2, 4
Labetalol can be administered as an initial 0.3-1.0 mg/kg dose (maximum 20 mg) slow IV injection every 10 min or 0.4-1.0 mg/kg/h IV infusion, according to the American Heart Association 1, 2
Nicardipine can be administered as an initial 5 mg/h, increasing every 5 min by 2.5 mg/h to maximum 15 mg/h, as recommended by the European Society of Cardiology 1, 2

Reinstituting or intensifying oral antihypertensive therapy is recommended by the American Heart Association 1, 2
Arranging close follow-up and avoiding rapid BP reduction with short-acting agents like immediate-release nifedipine are crucial in managing hypertensive urgency, as suggested by the European Society of Cardiology 5, 6

Excessive falls in BP may precipitate renal, cerebral, or coronary ischemia, highlighting the importance of careful BP management, as warned by the American College of Cardiology 5, 6
Patients with chronic hypertension often tolerate higher BP levels than previously normotensive individuals due to altered autoregulation, according to the American Heart Association 1, 2
For patients with ischemic stroke, there is limited evidence supporting immediate antihypertensive treatment, as noted by the European Stroke Organisation 5, 6
For BP ≥180/110 mmHg, fundoscopy is recommended to assess for hypertensive retinopathy, as suggested by the European Society of Cardiology 4

Using short-acting nifedipine in the initial treatment of hypertensive emergencies or urgencies is not recommended by the American Heart Association 5, 6
Reducing BP too rapidly or to normal levels immediately in patients with chronic hypertension can be harmful, as warned by the American College of Cardiology 1, 2
Discharging patients with hypertensive emergency before adequate BP control and transition to oral therapy is not recommended by the American Heart Association 1, 2
Overlooking potential secondary causes of severe hypertension, especially in younger patients or those with resistant hypertension, is a common pitfall to avoid, as noted by the European Society of Cardiology 4

Hypertensive urgency (BP >180/120 mmHg WITHOUT acute target organ damage) should be managed with oral antihypertensive medications and outpatient follow-up within 2-4 weeks—NOT with IV medications or hospital admission, as recommended by the American Heart Association 7
The rate of BP rise may be more important than the absolute value in determining the need for intervention, according to the American College of Cardiology 7

For patients with hypertensive urgency without target organ damage, oral antihypertensive therapy is recommended, with a goal of reducing blood pressure to <130/80 mmHg (or <140/90 mmHg in elderly/frail patients) within 3 months, as suggested by the American Heart Association 7
Patients with a history of cardiovascular disease should target a systolic BP of 120-129 mmHg to reduce cardiovascular risk, as recommended by the American College of Cardiology 7

For patients with a history of heart failure (especially EF <40%), prioritizing ACE inhibitor or ARB, adding beta-blocker, and adding aldosterone receptor antagonist if EF <40% is recommended, according to the American Heart Association 7
For patients with cardiovascular disease, fixed-dose single-pill combination treatment including RAS blocker, calcium channel blocker, and diuretic may be considered to improve adherence, as suggested by the American College of Cardiology 7

Admitting patients with asymptomatic hypertension without evidence of acute target organ damage, using IV medications for hypertensive urgency, and rapidly lowering BP in hypertensive urgency should be avoided, as recommended by the American Heart Association 7